Compare GSK plc (GSK) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs JPMorgan Chase & Co — how do they compare? GSK plc trades at $50.37 (market cap $102.60B), while JPMorgan Chase & Co trades at $365.24 (market cap $962.37B). The key difference: JPMorgan Chase & Co is far larger — about 9.4× GSK plc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | JPM | |
|---|---|---|
Market Cap | $102.60B | $962.37B |
Sector | Health | Financials |
52-Week High | $61.18 | $362.04 |
52-Week Low | $38.22 | $282.84 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | 1.66% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
JPMorgan Chase & Co. (JPM) trades at $362.04, up 0.63% daily, with a bullish technical outlook and strong earnings beats in recent quarters. The stock shows robust fundamentals, including a P/E of 15.51 and ROE of 18.43%, supported by revenue growth to $181.85B in 2025. Recent news highlights CEO Jamie Dimon's economic warnings and positive analyst sentiment ahead of Q1 2026 earnings.
Outlook is positive with a consensus price target of $374.18, offering ~3.4% upside, but risks include geopolitical tensions, cybersecurity threats, and volatile cash flows. Investors should weigh strong profitability against macroeconomic headwinds for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
